Daré Bioscience to Participate in Maxim Group Women's Health Panel

SAN DIEGO, July 07, 2022 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE ), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and CEO, will be participating in a virtual panel discussion presented by Maxim Group LLC and hosted by M-Vest, on July 13, 2022 at 11:00 a.m. ET. Additional information regarding the panel is set forth below. Title: "A Tipping Point in Women's Health - Does the SCOTUS Outcome Change the Paradigm in Contraception?" Moderator: Jason McCarthy, Ph.D., Senior Managing Director and Head of Biotechnology Research – Equity Research at Maxim Group. Panelists: Al Altomari, CEO, Agile Therapeutics, Inc. (AGRX) Sabrina Martucci Johnson, CEO, Daré Bioscience, Inc. (DARE) Kathy Lee-Sepsick, CEO, Femasys Inc. (FEMY) The panel will be hosted on Maxim's M-Vest website and available to its members. For more information, please visit https://m-vest.com/events/womens-health-panel-07132022 An archived webcast of the panel will be available from July 15 – 28, 2022, under "Presentations, Events & Webcasts" in the Investors section of the company's ... Full story available on Benzinga.com